These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 38754628

  • 1. Topical versus oral corticosteroids in moderate drug reaction with eosinophilia and systemic symptoms: A multicenter randomized clinical trial.
    Ingen-Housz-Oro S, Guichard E, Milpied B, Bensaid B, Collet E, Barbaud A, Le Duff F, Tétart F, Soria A, Machet L, Descamps V, Monestier S, Pasteur J, Morice C, Chaby G, Colin A, Grégoire L, Allanore L, Giraudeau B, Chosidow O.
    J Am Acad Dermatol; 2024 Sep; 91(3):544-547. PubMed ID: 38754628
    [No Abstract] [Full Text] [Related]

  • 2. Systemic Versus Topical Corticosteroids in the Treatment of DRESS: A Retrospective Cohort Study Followed by a Meta-Analysis.
    Lian BS, Ha JH, Sultana R, Chan LCE, Choo KJL, Yeo YW, Lee HY.
    Am J Clin Dermatol; 2023 Jul; 24(4):637-647. PubMed ID: 37133714
    [Abstract] [Full Text] [Related]

  • 3. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
    Cardones AR.
    Clin Dermatol; 2020 Jul; 38(6):702-711. PubMed ID: 33341203
    [Abstract] [Full Text] [Related]

  • 4. Hair loss after drug reaction with eosinophilia and systemic symptoms (DRESS): A multicentric retrospective case series.
    Lee JW, Yu DA, Cho S, Youn SW, Kwon O.
    J Dermatol; 2023 Jun; 50(6):814-819. PubMed ID: 36651019
    [Abstract] [Full Text] [Related]

  • 5. Cyclosporine as an alternative immunosuppressant for steroid-resistant drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
    Tan K, Testro A.
    BMJ Case Rep; 2023 Mar 21; 16(3):. PubMed ID: 36944441
    [Abstract] [Full Text] [Related]

  • 6. Impact of systemic to topical steroids switch on the outcome of drug reaction with eosinophilia and systemic symptoms (DRESS): A monocenter retrospective study of 20 cases.
    Brin C, Bernigaud C, Hua C, Duong TA, Gaudin O, Colin A, de Prost N, Wolkenstein P, Chosidow O, Ingen-Housz-Oro S.
    Ann Dermatol Venereol; 2021 Sep 21; 148(3):168-171. PubMed ID: 33858692
    [Abstract] [Full Text] [Related]

  • 7. Drug reaction with eosinophilia and systemic symptoms: An emergency medicine focused review.
    Gottlieb M, Figlewicz MR, Rabah W, Buddan D, Long B.
    Am J Emerg Med; 2022 Jun 21; 56():1-6. PubMed ID: 35338896
    [Abstract] [Full Text] [Related]

  • 8. DRESS syndrome: a detailed insight.
    Behera SK, Das S, Xavier AS, Selvarajan S.
    Hosp Pract (1995); 2018 Aug 21; 46(3):152-162. PubMed ID: 29519170
    [Abstract] [Full Text] [Related]

  • 9. Drug reaction with eosinophilia and systemic symptoms after ocrelizumab therapy.
    Nylund M, Vuorinen T, Airas L.
    Mult Scler Relat Disord; 2020 Jul 21; 42():102058. PubMed ID: 32208345
    [Abstract] [Full Text] [Related]

  • 10. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management.
    Wei BM, Fox LP, Kaffenberger BH, Korman AM, Micheletti RG, Mostaghimi A, Noe MH, Rosenbach M, Shinkai K, Kwah JH, Phillips EJ, Bolognia JL, Damsky W, Nelson CA.
    J Am Acad Dermatol; 2024 May 21; 90(5):911-926. PubMed ID: 37516356
    [Abstract] [Full Text] [Related]

  • 11. Corticosteroid-induced drug reaction with eosinophilia and systematic symptoms successfully treated with a tumor necrosis factor alpha inhibitor.
    Kim S, Joo EJ, Kim UJ, Kim JH, Kim B, Lee HJ, Chae SW, Kim HN, Cheong HS.
    Asian Pac J Allergy Immunol; 2022 Dec 21; 40(4):418-421. PubMed ID: 32170921
    [Abstract] [Full Text] [Related]

  • 12. Two cases with HSS/DRESS syndrome developing after prosthetic joint surgery: does vancomycin-laden bone cement play a role in this syndrome?
    Güner MD, Tuncbilek S, Akan B, Caliskan-Kartal A.
    BMJ Case Rep; 2015 May 28; 2015():. PubMed ID: 26021379
    [Abstract] [Full Text] [Related]

  • 13. [DRESS syndrome induced by sulfasalazine. Report of one case].
    Arce E, Quera R, Flores L, Blamey R.
    Rev Med Chil; 2020 Aug 28; 148(8):1213-1218. PubMed ID: 33399789
    [Abstract] [Full Text] [Related]

  • 14. Drug Reaction, Eosinophilia and Systemic Symptoms (DRESS) syndrome secondary to allopurinol with early lymphadenopathy and symptom relapse.
    Turney R, Skittrall JP, Donovan J, Agranoff D.
    BMJ Case Rep; 2015 Oct 05; 2015():. PubMed ID: 26438678
    [Abstract] [Full Text] [Related]

  • 15. Drug reaction with eosinophilia and systemic symptoms syndrome is not uncommon and shows better clinical outcome than generally recognised.
    Nam YH, Park MR, Nam HJ, Lee SK, Kim KH, Roh MS, Um SJ, Son CH.
    Allergol Immunopathol (Madr); 2015 Oct 05; 43(1):19-24. PubMed ID: 24388810
    [Abstract] [Full Text] [Related]

  • 16. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome after topical use of Nigella sativa (black cumin) oil.
    Fargeas M, Calugareanu A, Ben-Said B.
    Contact Dermatitis; 2022 Aug 05; 87(2):203-204. PubMed ID: 35419842
    [No Abstract] [Full Text] [Related]

  • 17. Clinical features, treatment outcomes and prognostic factors of allopurinol-induced DRESS in 52 patients.
    Liu Q, Zhao S, Chen W.
    J Clin Pharm Ther; 2022 Sep 05; 47(9):1368-1378. PubMed ID: 35971667
    [Abstract] [Full Text] [Related]

  • 18. Drug reaction eosinophilia and systemic symptoms: Clinical phenotypic patterns according to causative drug.
    Blumenthal KG, Alvarez-Arango S, Kroshinsky D, Lo YC, Samarakoon U, Salem AR, Fu X, Bassir F, Wang L, Jaggers J, Phillips E, Zhou L.
    J Am Acad Dermatol; 2024 Jun 05; 90(6):1240-1242. PubMed ID: 37276931
    [No Abstract] [Full Text] [Related]

  • 19. Is steroid pulse therapy a suitable treatment for drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms? A systematic review of case reports in patients treated with corticosteroids in Japan.
    Hashizume H, Ishikawa Y, Ajima S.
    J Dermatol; 2022 Feb 05; 49(2):303-307. PubMed ID: 34755354
    [Abstract] [Full Text] [Related]

  • 20. Probable Griseofulvin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms in a Child.
    Smith RJ, Boos MD, McMahon P.
    Pediatr Dermatol; 2016 Sep 05; 33(5):e290-1. PubMed ID: 27397873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.